30 Years of Evidence
Featured Content
PROSTATE cancer
Comprehensive one-day management of prostate cancer patients: PRO-FAST single-fraction ablative, urethral-sparing, HDR-like, robotic SBRT
SPINAL CANCER
Efficacy and Safety of Donut-Shaped Circumferential Spine CyberKnife Stereotactic Body Radiotherapy for Metastatic Spine Disease
BREAST CANCER
Ablative Preoperative Single-Fraction Radiation Dose Escalation Among Patients With Breast Cancer: A Phase 1 Nonrandomized Clinical Trial
Clinical outcomes and dosimetry of root entry zone-targeted radiosurgery for trigeminal neuralgia
Bhooshan Zade | ESTRO | 2026
Radiobiological dose and treatment duration influence pain relief and sensory outcomes in CyberKnife radiosurgery for trigeminal neuralgia
Evangelos Pantelis, Greece | ESTRO | 2026
Dosimetric comparison of left-sided accelerated partial breast irradiation (APBI) performed with conventional linear accelerator and CyberKnife
Enikő Koszta, Hungary | ESTRO | 2026
Five-Fraction Whole- and Partial-Breast Irradiation Using Helical Tomotherapy: Comparative Dosimetry and Early Clinical Outcomes
Yu-Hsuan Chuang, Taiwan, Province of China | ESTRO | 2026
Automated DIBH breast radiotherapy using TomoDirect and VitalHold on a ring?based LINAC: feasibility, dosimetry and early tolerance
Paul RETIF, France | ESTRO | 2026
Stereotactic Accelerated Partial Breast Irradiation Using CyberKnife – 5-Year Results of a single-institution Phase II trial.
Norbert Mészáros, Hungary | ESTRO | 2026
Preoperative radiotherapy in a single fraction for early stage breast cancer: the CRYSTAL phase I/II study update (AIRC IG-23118)
Maria Alessia Zerella | ESTRO | 2026
Dosimetric analysis for single fraction radiation therapy in breast cancer: CRYSTAL trial
Marco Lucarell | ESTRO | 2026
Correlations of biochemical and clinical outcomes with 10-year results after robotic stereotactic body radiotherapy for localized prostate cancer
Kim JS , Park Y, Park HJ, Jang WI, Jeong BK, Kim H-J, Chang AR. Radiat Oncol. 2025 Oct 23;20(1):157. doi: 10.1186/s13014-025-02739-z. PMID 41131547
Time-resolved Biological Effective Dose Distributions in Stereotactic Radiosurgery for Vestibular Schwannomas: A Comparative Analysis Between Two Dedicated Stereotactic Radiosurgery Systems
Moutsatsos A, Cotrutz C, Stergioula A, Tuleasca C, Pantelis E | Phys Med Biol | 2025
Long-term Outcomes of Ablative Stereotactic Body Radiation Therapy for Inoperable, Non-metastatic Pancreatic Cancer
Cao BY, Zhang LT, Wu CC, Wang J | Radiother Oncol. | 2025
Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract
Zhang Z, Tian B, Xu H, Huang H, Liang X, Bo C, Bian Y, Wei M, Zhao Z | Cancer Manag Res | 2025
Stereotactic Reirradiation with CyberKnife for Locally Recurrent Prostate Cancer, Long-term Toxicity and Clinical Outcomes from a Monocentric Cohort
Francolini G, Carnevale MG, Di Cataldo V, Loi M, Detti B, Orsatti C, Caprara L, Bertini N, Lorenzetti V, Olmetto E, Becherini C, Visani L, Salvestrini V, Simontacchi G, Greto D, Bonomo P, Doro R, Masi L, Desideri I, Meattini I, Serni S, Livi L | Radiol Med | 2023
Stereotactic body radiation therapy for intermediate-risk prostate cancer: efficacy and toxicity
María Dolores Espinosa Cuesta | ESTRO | 2026
DVH-based analysis of genitourinary side effects in robotic SBRT prostate treatments
David Sevillano, Spain | ESTRO | 2026
Planning, patient QA and image-guidance aspects of single-fraction, one-Day robotic SBRT for localized prostate cancer.
SARA BROGGI, Italy | ESTRO | 2026
Cyberknife Radiosurgery of Prostate Cancer – Results for 200 Patients
Sebastian Exner, Germany | ESTRO | 2026
Volumetric analysis of Vestibular Schwannoma after Cyberknife Stereotactic Radiosurgery/SBRT: single center study
Maris Mezeckis, Latvia | ESTRO | 2026
Anlotinib Plus Radiotherapy for Newly Diagnosed Pediatric Malignant Brainstem Gliomas: Safety and Efficacy Evaluation
Ying Wang, China | ESTRO | 2026
Cyberknife Stereotactic Radiosurgery For Vestibular Schwannoma: 9-Year Single-Centre Experience
Sandra Lediņa, Latvia | ESTRO | 2026